此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Evaluation of the Effect of Virtual Reality Application on Postoperative Pain and Anxiety in Women (Pain)

2026年11月15日 更新者:Songul Gungor、Osmaniye Korkut Ata University

Effects of a Nature-Based Virtual Reality Intervention on Postoperative Pain and Anxiety in Women Undergoing Total Knee Arthroplasty or Cesarean Delivery: A Randomized Controlled Study

Surgical interventions, while significant milestones in patients' physical recovery processes, can be a major source of concern for patients due to postoperative pain, which is also an important component of postoperative care. If postoperative pain is not managed properly, it can lead to increased levels of anxiety and fear, as well as deterioration in overall comfort and quality of life. The ineffective management of postoperative pain has economic and medical consequences such as patient dissatisfaction, delayed hospital discharge, increased rates of hospital readmission, and dissatisfaction with medical care. Therefore, effective management of postoperative pain is of great importance for patient well-being. Factors associated with postoperative pain have been reported in many studies. For example, being female and the type of surgery. Therefore, considering gender and type of surgery in the management of postoperative pain is crucial to optimize the recovery process for patients. In recent years, research on the use of innovative technologies such as virtual reality in the management of postoperative pain has increased. Virtual reality can reduce postoperative pain by creating a sense of being in a different environment for patients and diverting their attention away from pain.

研究概览

地位

完全的

详细说明

This randomized controlled trial evaluated the effects of virtual reality (VR) on postoperative pain, anxiety, physiological parameters, and analgesic use in women aged 18 years and older undergoing total knee arthroplasty (TKA) or cesarean section (CS) at Osmaniye State Hospital. The study also examined whether the effects of VR differed by surgery type.

Within each surgery category, eligible participants were assigned to VR or control groups using a lottery method performed by clinical nurses who were not members of the research team. Folded slips indicating VR or control allocation were drawn from a box, resulting in four groups: VR-TKA, control-TKA, VR-CS, and control-CS. Participants, the intervention provider, and the outcome assessor were aware of group allocation.

Baseline assessments (T1) were performed at postoperative hour 24, 40 minutes after analgesic administration. Pain and anxiety were assessed using separate 10-cm Visual Analog Scales (VAS). Physiological measurements included systolic and diastolic blood pressure, pulse rate, and peripheral oxygen saturation (SpO₂).

Participants in the VR groups received a 10-minute VR session in addition to routine postoperative care. They selected one of four relaxing nature videos featuring lake and river scenery, the sea and a tropical beach, morning nature scenes, or forest scenery. The device and planned intervention duration were standardized, while content selection reflected individual preferences. Videos were presented without headphones at the device's maximum volume. Control groups received routine postoperative care without VR. All assessments were repeated immediately after the 10-minute intervention or corresponding control period (T2). VR sessions and assessments were conducted with participants in a semi-sitting position in bed.

Analgesic use was obtained from patient records and medication administration charts. Video preferences, intervention completion, and participants' feedback regarding their VR experience were recorded. When participants reported dizziness, the video was stopped. Sixteen participants discontinued VR because of dizziness; the final analyses included 126 participants who completed the study: 36 in VR-TKA and 30 in each of the other three groups.Analgesic use was obtained from patient records and medication administration charts. Video preferences, intervention completion, participants' feedback regarding their VR experience, and the occurrence of dizziness during the VR session were recorded. When participants reported dizziness, the video was stopped, and their T2 assessments were performed at the time the headset was removed. Sixteen participants discontinued VR because of dizziness.

The primary analysis included all 142 randomized participants in the groups to which they were assigned (intention-to-treat), using analysis of covariance (ANCOVA) with the T2 score as the dependent variable, the T1 score as the covariate, and VR status and surgery type as fixed factors, including their interaction. Two sensitivity analyses were performed: a conservative analysis in which the T1 scores of participants who discontinued VR were carried forward as their T2 scores (n = 142), and a per-protocol analysis including only participants who completed the intervention (n = 126: 36 in VR-TKA and 30 in each of the other three groups). The primary models were also repeated with age as an additional covariate.

The study was initially approved by the Osmaniye Korkut Ata University Ethics Committee on November 29, 2023 (Decision No. 2023/8/3), and institutional permission was obtained from Osmaniye State Hospital on December 22, 2023. However, after the gynecologic surgeons left the hospital, hysterectomy procedures were no longer performed, and eligible hysterectomy patients could not be recruited. Therefore, the hysterectomy group was replaced with a cesarean section group, and a protocol amendment was approved by the ethics committee on March 2, 2026 (Decision No. 2026/3/2). Recruitment of cesarean section participants began after this amendment was approved.Data for the total knee arthroplasty groups were collected between January 2024 and December 2024 under the initial ethics approval. Data for the cesarean section groups were collected between March 2026 and November 2026, after the protocol amendment had been approved. Ethical approval was obtained from the Osmaniye Korkut Ata University Ethics Committee (Decision No. 2023/8/3, November 29, 2023), and institutional permission was obtained from Osmaniye State Hospital (December 22, 2023). A protocol amendment replacing the hysterectomy group with a cesarean section group was approved on March 2, 2026 (Decision No. 2026/3/2). Written informed consent was obtained from all participants, and the study was conducted in accordance with the Declaration of Helsinki.

研究类型

介入性

注册 (实际的)

76

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Osmani̇ye
      • Center、Osmani̇ye、土耳其(türkiye)、80010
        • Osmaniye Korkut Ata University
      • Center、Osmani̇ye、土耳其(türkiye)、80010
        • Osmaniye State Hospital

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 85年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

女性

描述

Inclusion Criteria:

  • Being female and aged 18 years or older.
  • Having undergone total knee arthroplasty or cesarean section.
  • Being at postoperative hour 24.
  • Being conscious and able to communicate.
  • Being able to understand the assessment instruments.
  • Having no severe visual or hearing impairment or physical condition that would prevent the use of a VR headset.

Exclusion Criteria:

  • Having severe cognitive or communication difficulties.
  • Experiencing deterioration in clinical condition.
  • Having a neurological or vestibular disorder.
  • Experiencing active nausea or vomiting.
  • Having an active eye infection.
  • Having wounds in the facial or head region that would interfere with VR headset use.

Withdrawal Criterion:

- Requesting withdrawal from the study.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:支持治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
实验性的:Total Knee Replacement VR Intervention Group

Participants who underwent total knee arthroplasty completed baseline assessments (T1) of pain and anxiety using separate 10-cm Visual Analog Scales (VAS), along with measurements of systolic and diastolic blood pressure, pulse rate, and SpO₂. They then received a 10-minute VR intervention in addition to routine postoperative care. All assessments were repeated immediately after the intervention (T2).

Participants undergoing VR intervention will experience a VR program of their choice based on personal preferences. Among these programs are videos offering natural visual experiences. For instance, participants can opt for videos featuring seaside views, forest tours, or lake landscapes.

无干预:Total Knee Replacement Control Group

Participants who underwent total knee arthroplasty completed baseline assessments (T1) of pain and anxiety using separate 10-cm Visual Analog Scales (VAS), along with measurements of systolic and diastolic blood pressure, pulse rate, and SpO₂. They received routine postoperative care without VR. All assessments were repeated after the same 10-minute interval used in the VR group (T2).

实验性的:Cesarean Section VR Intervention Group

Pre-Test + Intervention + Post-Test) Participants who underwent cesarean section surgery and received a pre-test, followed by VR intervention.Participants in this group are initially assessed with a pre-test, followed by VR intervention.

Participants undergoing VR intervention will experience a VR program of their choice based on personal preferences. Among these programs are videos offering natural visual experiences. For instance, participants can opt for videos featuring seaside views, forest tours, or lake landscapes.

无干预:Total Knee Group

Participants who underwent total knee arthroplasty completed baseline assessments (T1) of pain and anxiety using separate 10-cm Visual Analog Scales (VAS), along with measurements of systolic and diastolic blood pressure, pulse rate, and SpO₂. They received routine postoperative care without VR. All assessments were repeated after the same 10-minute interval used in the VR group (T2).

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
The VR application is effective in changing postoperative pain.
大体时间:The researcher's first visit to the patient on postoperative day 1.

Pain intensity was assessed using a 10-cm Visual Analog Scale (VAS) in women aged 18 years and older undergoing total knee arthroplasty or cesarean section. Baseline assessments (T1) were performed at postoperative hour 24, 40 minutes after analgesic administration. Participants in the VR groups then received a 10-minute VR intervention alongside routine care, while control groups continued to receive routine care alone. Pain intensity was reassessed (T2) immediately after this 10-minute period in all groups.

The researcher's first visit to the patient on postoperative day 1.

次要结果测量

结果测量
措施说明
大体时间
The VR application is effective in changing postoperative anxiety.
大体时间:The researcher's first visit to the patient on postoperative day 1.

Pain intensity was assessed using a 10-cm Visual Analog Scale (VAS) in women aged 18 years and older undergoing total knee arthroplasty or cesarean section. Baseline assessments (T1) were performed at postoperative hour 24, 40 minutes after analgesic administration. Participants in the VR groups then received a 10-minute VR intervention alongside routine care, while control groups continued to receive routine care alone. Pain intensity was reassessed (T2) immediately after this 10-minute period in all groups.

The researcher's first visit to the patient on postoperative day 1.

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Songül GÜNGÖR, Phd、Osmaniye Korkut Ata University
  • 研究主任:Ayşe TAŞTEKİN, associate professor、Afyonkarahisar Health Sciences University

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年4月15日

初级完成 (实际的)

2026年11月1日

研究完成 (实际的)

2026年11月1日

研究注册日期

首次提交

2024年3月2日

首先提交符合 QC 标准的

2024年5月28日

首次发布 (实际的)

2024年5月30日

研究记录更新

最后更新发布 (实际的)

2026年11月18日

上次提交的符合 QC 标准的更新

2026年11月15日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅